Reauthorization of the Federal Trade Commission: Positioning the Commission for the Twenty-first Century : Hearing Before the Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, First Session, June 11, 2003 |
Other editions - View all
Common terms and phrases
activities addition agency's alleged amended anticompetitive antitrust authority civil penalties Colorado Commissioner Swindle committee common carrier companies competition CONGRES CONGRESS THE LIBRARY consumer complaints consumer protection consumer reporting agencies cooperation credit reporting agencies criminal database deceptive spam Do-Not-Call drugs efforts FCRA Federal Trade Commission filed fraud and deception fraudulent FTC Act FTC staff FTC's ability gasoline prices hearing ID theft identity theft industry Internet investigation issues jurisdiction knowledge standard law enforcement law enforcement actions law enforcement agencies LEARY lenders LIBRARY CONGRESS LIBRARY OF CONGRESS marketplace ment mergers million mission Mortgage MURIS Office outreach patent practices problem prosecution protect consumers question reauthorization regulations Response scams SCHAKOWSKY Sentinel settlement SHADEGG share information spam spammer STEARNS subcommittee sumer targets telecommunications telemarketing Thank THOMPSON tion unfair Unocal unsolicited commercial e-mail victims violations
Popular passages
Page 23 - Applications for FDA Approval to Market a New Drug: Patent Listing Requirements and Application of 30-Month Stays on Approval of Abbreviated New Drug Applications Certifying That a Patent Claiming a Drug Is Invalid or Will Not Be Infringed; Proposed Rule, 67 Fed.
Page 9 - He's at the health conference. [Additional statements submitted for the record follow:] PREPARED STATEMENT OF HON. BARBARA CUBIN, A REPRESENTATIVE IN CONGRESS FROM THE STATE OF WYOMING Thank you, Mr. Chairman. I...
Page 58 - The Honorable JOHN D. DINGELL Ranking Member Committee on Energy and Commerce US House of Representatives Washington, DC 20515-6115 DEAR MR.
Page 1 - HOUSE OF REPRESENTATIVES, COMMITTEE ON ENERGY AND COMMERCE, SUBCOMMITTEE ON COMMERCE, TRADE, AND CONSUMER PROTECTION, Washington, DC. The subcommittee met, pursuant to notice, at 10 am, in room 2322 Rayburn House Office Building, Hon.
Page 62 - System; the Office of the Comptroller of the Currency; the Office of Thrift Supervision; the Federal Deposit Insurance Corporation...
Page 58 - The subcommittee is adjourned. [Whereupon, at 12:15 pm, the subcommittee was adjourned.] [Additional material submitted for the record follows...
Page 25 - ... minimizing policy and enforcement divergences. ICN. In 2001, the FTC, the DOJ, and 12 other antitrust agencies from around the world launched the International Competition Network ("ICN"). The ICN is an outgrowth of a recommendation of the International Competition Policy Advisory Committee ("ICPAC") that competition officials from developed and developing countries convene a forum in which to work together on competi65 FTC Press Release, FTC Competition Director Announces Guidelines for Negotiating...
Page 24 - ... complaints into its ongoing analysis of gasoline prices around the country, using the complaints to help locate price anomalies outside of the 360 cities for which the staff already receives daily pricing data. The goal of the Monitoring Project is to alert the FTC to unusual changes in gasoline prices so that further inquiry can be undertaken expeditiously. When price increases do not appear to have market-driven causes, the FTC staff will consult with the Energy Information Agency of the Department...
Page 21 - C-4060 (Oct 2, 2002) (consent order to settle charges that Biovail illegally acquired a license to a patent and improperly listed the patent in the FDA's Orange Book as claiming Biovail's high blood pressure drug Tiazac).
Page 22 - For example, in April 2003, the Commission reached a settlement with Pfizer Inc.. the largest pharmaceutical company in the United States, and Pharmacia Corporation to resolve concerns that their $60 billion merger would harm competition in nine separate and wide-ranging product markets, including drugs to treat overactive bladder, symptoms of menopause, skin conditions, coughs, motion sickness, erectile dysfunction, and three different veterinary conditions. Annual sales in the nine product markets...